Clinical Trial Update: Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma [Phase 1]

View source ↗

Summary

This document provides an update on a Phase 1 clinical trial evaluating combination chemotherapy for patients with relapsed or refractory aggressive non-Hodgkin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Snippet

Sponsor: Theradex | Conditions: Lymphoma | Phase 1 | Status: UNKNOWN